Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment
Hélène Nougue(Délégation Paris 5), Nicolas Vodovar(Institut Pasteur), Johan Lassus(University of Helsinki), Alain Cohen‐Solal(Inserm), Sai͏̈d Laribi(Université de Tours), Damien Logeart(Inserm), Jean‐Marie Launay(Université Claude Bernard Lyon 1), François Picard(Université de Bordeaux), Michel Thibault(Inserm), Malha Sadoune(Inserm)
Cited by 6
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
|European Journal of Preventive Cardiology|2020|924
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837